Movement Alert｜Medtronic PLC Intraday Rise 3.1%, Affera Prism-2 Mapping Software Secures FDA Clearance and CE Mark

Market Focus

Oct 09

On October 9, Medtronic PLC rose 3.1% in regular trading, trading at $88.15/share with Turnover of $39.21 billion. The move follows the announcement that the company's Affera Prism-2 Mapping Software received US FDA clearance and a CE Mark, while the PulseSelect ProxBox Adapter software obtained a CE Mark, expanding its cardiac ablation product line.

The Affera application generates three-dimensional maps of electrical activity in the heart to guide physicians during arrhythmia treatments, while the PulseSelect upgrade delivers real-time feedback to help doctors evaluate catheter proximity to targeted tissue before applying energy. This follows the recent FDA clearance for LigaSure RAS Maryland device on Hugo system and a strategic partnership with Cornerstone Robotics, further strengthening Medtronic's competitive position across cardiac ablation and robotic surgery segments.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketl.com/news/1131711690"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1131711690\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1131711690?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-09 01:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1131711690","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Medtronic PLC Intraday Rise 3.1%, Affera Prism-2 Mapping Software Secures FDA Clearance and CE Mark","media":"Market Focus","content":"<p><p>On October 9, Medtronic PLC rose 3.1% in regular trading, trading at $88.15/share with Turnover of $39.21 billion. The move follows the announcement that the company's Affera Prism-2 Mapping Software received US FDA clearance and a CE Mark, while the PulseSelect ProxBox Adapter software obtained a CE Mark, expanding its cardiac ablation product line.</p><p>The Affera application generates three-dimensional maps of electrical activity in the heart to guide physicians during arrhythmia treatments, while the PulseSelect upgrade delivers real-time feedback to help doctors evaluate catheter proximity to targeted tissue before applying energy. This follows the recent FDA clearance for LigaSure RAS Maryland device on Hugo system and a strategic partnership with Cornerstone Robotics, further strengthening Medtronic's competitive position across cardiac ablation and robotic surgery segments.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Medtronic PLC Intraday Rise 3.1%, Affera Prism-2 Mapping Software Secures FDA Clearance and CE Mark</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Medtronic PLC Intraday Rise 3.1%, Affera Prism-2 Mapping Software Secures FDA Clearance and CE Mark\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-10-09 01:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On October 9, Medtronic PLC rose 3.1% in regular trading, trading at $88.15/share with Turnover of $39.21 billion. The move follows the announcement that the company's Affera Prism-2 Mapping Software received US FDA clearance and a CE Mark, while the PulseSelect ProxBox Adapter software obtained a CE Mark, expanding its cardiac ablation product line.</p><p>The Affera application generates three-dimensional maps of electrical activity in the heart to guide physicians during arrhythmia treatments, while the PulseSelect upgrade delivers real-time feedback to help doctors evaluate catheter proximity to targeted tissue before applying energy. This follows the recent FDA clearance for LigaSure RAS Maryland device on Hugo system and a strategic partnership with Cornerstone Robotics, further strengthening Medtronic's competitive position across cardiac ablation and robotic surgery segments.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MDT","symbol_name":"美敦力","start_time":0,"source_url":"","article_id":"1131711690","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1131711690","pubTimestamp":1791478800,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On October 9, Medtronic PLC rose 3.1% in regular trading, trading at $88.15/share with Turnover of $39.21 billion. The move follows the announcement that the company's Affera Prism-2 Mapping Software...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MDT":"美敦力"},"translate_title":"走势警报|美敦力PLC盘中上涨3.1%，Affera Prism-2绘图软件获得FDA批准和CE标志","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDT":1},"content_text":"On October 9, Medtronic PLC rose 3.1% in regular trading, trading at $88.15/share with Turnover of $39.21 billion. The move follows the announcement that the company's Affera Prism-2 Mapping Software received US FDA clearance and a CE Mark, while the PulseSelect ProxBox Adapter software obtained a CE Mark, expanding its cardiac ablation product line.The Affera application generates three-dimensional maps of electrical activity in the heart to guide physicians during arrhythmia treatments, while the PulseSelect upgrade delivers real-time feedback to help doctors evaluate catheter proximity to targeted tissue before applying energy. This follows the recent FDA clearance for LigaSure RAS Maryland device on Hugo system and a strategic partnership with Cornerstone Robotics, further strengthening Medtronic's competitive position across cardiac ablation and robotic surgery segments.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}